Enhanced Group Inc ENHA 深 沪
已收盘 11-13 16:00:00 美东时间
6.67
-0.530
-7.36%
华盛通- 最 高8.00
- 今 开7.92
- 成交量 23.86万股
- 最 低 5.745
- 昨 收 7.20
- 总市值 26.39万
- 52周最高 101.70
- 市盈率 静 55.22
- 换手率 0.60%
- 52周最低 5.745
- 委 比 -1.64%
- 总股本 3.96万
- 历史最高 14.09
- 量 比 3.23
- 振 幅 31.32%
- 历史最低 5.745
- 每 手 1
- 风险率 14.85%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 潜在涨幅332.55%！Viking Therapeutics获上调目标价至118美元，维持"买入"评级
今日重点评级关注：Canaccord Genuity：维持Viking Therapeutics"买入"评级，目标价从106美元升至118美元；Canaccord Genuity：维持Aclaris Therapeutics"买入"评级，目标价从10美元升至13美元
11-02 18:53
Canaccord Genuity Maintains Buy on Enhanced Group, Raises Price Target to $17
Canaccord Genuity analyst Susan Anderson maintains Enhanced Group (NYSE:ENHA) with a Buy and raises the price target from $5 to $17.
10-31 08:41
Reported Earlier: Enhanced Group Announces 1-For-10 Reverse Stock Split, Effective Immediately
Enhanced Group Inc. (NYSE: ENHA) (“Enhanced” or the “Company”) today announced that its previously announced 1-for-10 reverse stock split of its Class A and Class B common stock (the “Reverse Stock Split”) has gone effective. Enhanced’s Class A common stock will begin trading on a split-adjusted bas...
10-29 22:41
Enhanced Group board approves 1-for-10 reverse stock split
Enhanced Group(ENHA) announced that its board of directors, backed by written consent from the majority voting shareholder has approved a 1-for-10 reverse stock split of its Class A and Class B common...
09-29 12:54
美股大行评级 | 汽车地带绩后遭10家机构降目标价！最低看至3000美元；美光、微软、Meta齐获看多
今日重点评级关注：Leerink Partners：维持塞德斯医疗"跑赢大市"评级，目标价从70美元升至88美元；HC Wainwright & Co.：维持TriSalus Life Sciences"买入"评级，目标价从11美元升至12美元
09-24 16:10
Cantor Fitzgerald Initiates Coverage On Enhanced Group with Overweight Rating, Announces Price Target of $4
Cantor Fitzgerald analyst Gabie Ingoglia initiates coverage on Enhanced Group (NYSE:ENHA) with a Overweight rating and announces Price Target of $4.
09-23 18:48
Enhanced Group Inc. GAAP EPS of -$0.27
Enhanced Group Inc. press release (ENHA): Q2 GAAP EPS of -$0.27. More on Enhanced Group Inc. Historical earnings data for Enhanced Group Inc. Financial information for Enhanced Group Inc.
08-27 04:29
美股大行评级 | 潜在涨幅455.56%！Cardiol Therapeutics获Canaccord Genuity上调目标价至10美元，维持"买入"评级
今日重点评级关注：Canaccord Genuity：维持Cardiol Therapeutics"买入"评级，目标价从8美元升至10美元；B. Riley证券：维持Macrogenics"买入"评级，目标价从9美元升至11美元
08-18 11:39
Canaccord Genuity Maintains Buy on Enhanced Group, Lowers Price Target to $5
Canaccord Genuity analyst Susan Anderson maintains Enhanced Group (NYSE:ENHA) with a Buy and lowers the price target from $6 to $5.
08-17 20:23
Enhanced Group Q2 EPS $(0.53), Sales $17.700M
Enhanced Group (NYSE:ENHA) reported quarterly losses of $(0.53) per share. The company reported $17.700 million in sales this quarter.
08-14 04:35
